Home › Funds › CONGRESS ASSET MANAGEMENT CO › HALO

CONGRESS ASSET MANAGEMENT CO position in HALO

HALOZYME THERAPEUTICS INC · Health Care

CONGRESS ASSET MANAGEMENT CO reported holding 2,281,615 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$251.9M, representing 1.64% of its reported portfolio and ranking #6 among its reported holdings. CONGRESS ASSET MANAGEMENT CO has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.28M sh
Reported value held$251.89M
Portfolio Weight1.64%
First reportedQ3 2023
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How CONGRESS ASSET MANAGEMENT CO's HALO position evolved

CONGRESS ASSET MANAGEMENT CO first disclosed a stake in HALO in Q3 2023 at 303,717 shares (US$11.6M). The position peaked in Q3 2026 at 2,281,615 shares, worth US$251.9M. Across 13 filings, CONGRESS ASSET MANAGEMENT CO increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,281,615 shares valued at US$251.9M — an increase of 1,052,509 shares quarter over quarter.. Notable position changes include a 446% increase in Q3 2024 (shares fell 16% over the following quarter), a 86% increase in Q3 2026 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 303.72K $11.60M New
Q4 2023 351.08K $12.98M Add
Q1 2024 407.87K $16.59M Add
Q2 2024 445.34K $23.32M Add
Q3 2024 2.43M $139.30M Add
Q4 2024 1.96M $93.69M Reduce
Q1 2025 2.13M $136.09M Add
Q2 2025 1.84M $95.48M Reduce
Q3 2025 1.44M $105.36M Reduce
Q4 2025 1.30M $87.64M Reduce
Q1 2026 1.28M $82.76M Reduce
Q2 2026 1.23M $96.20M Reduce
Q3 2026 2.28M $251.89M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HALO and 13F data

HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in HALO — the largest reported positions include WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$196.5M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), LOS ANGELES CAPITAL MANAGEMENT LLC (US$151.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HALO

All HALO fund holders →

FAQ

How long has CONGRESS ASSET MANAGEMENT CO held HALO?

CONGRESS ASSET MANAGEMENT CO has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CONGRESS ASSET MANAGEMENT CO's current position in HALO?

As of Q3 2026, CONGRESS ASSET MANAGEMENT CO holds 2.28M shares of HALO (HALOZYME THERAPEUTICS INC), valued at $251.89M, representing 1.64% of its reported portfolio and ranking #6.

Has CONGRESS ASSET MANAGEMENT CO been buying or selling HALO?

In the latest 13F filing (Q3 2026), CONGRESS ASSET MANAGEMENT CO increased its position in HALO. The position peaked in Q3 2026 at 2.28M shares.

Which other funds hold HALO?

Other major institutional holders of HALO include WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, LOS ANGELES CAPITAL MANAGEMENT LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.